Skip to main content
OpenTrials
Completed

NCT Number: NCT02556489

Transcriptomics Signature of Anti Vaccinia Memory B Cells

Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut Necker Enfants Malades U1151, Faculté de Médecine-Paris Descartes, site Broussais, Bâtiment Leriche, porte 9, CS 61431, 14 Rue Maria Helena V

Paris, 75293 Paris Cedex 14, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy donors vaccinated against smallpox

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. Analysis of B memory cells

    Time frame: 12 months

    B-memory cells will be analysed to determine, on an individual basis, whether they express the long-lived signature

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Registry information

Official study title

Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Sep 22, 2015
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.